Inhibition of trauma-associated inflammatory liver damage by blocking NF-κB activity

Wenjun Yang1, Yihu Zheng, Han He

  • 1Department of General Surgery, the First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China.

Hepato-Gastroenterology
|November 8, 2011
PubMed
Abstract

Insights

Inhibiting NF-κB activation significantly reduces liver damage and inflammation following trauma. This approach lowers key inflammatory markers, offering a potential therapeutic strategy for trauma-associated liver injury.

Area of Science:

  • Immunology
  • Molecular Biology
  • Hepatology

Background:

  • Nuclear factor-kappa B (NF-κB) proteins are crucial transcription factors regulating immune responses.
  • NF-κB plays a significant role in inflammatory signaling pathways.
  • Understanding NF-κB's role in trauma is vital for managing associated liver damage.

Purpose of the Study:

  • To investigate the role of NF-κB in the development of liver damage and inflammation after trauma.
  • To assess the therapeutic potential of inhibiting NF-κB activation in a trauma model.

Main Methods:

  • Utilized Wistar rats divided into control, trauma, NF-κB decoy ODN, and mutant NF-κB decoy ODN groups.
  • Inhibited NF-κB DNA-binding activity using double-stranded oligodeoxynucleotides (ODN).
  • Assessed liver damage via serum ALT levels, light microscopy, and transmission electron microscopy; measured NF-κB activation using EMSA.

Main Results:

  • Inhibition of NF-κB activation significantly reduced liver tissue damage and inflammation.
  • EMSA confirmed reduced NF-κB activation in the ODN group compared to control and mutant groups.
  • Expression of pro-inflammatory cytokines TNF-α and IL-6 was significantly decreased in the ODN group.

Conclusions:

  • NF-κB activation is a key mediator of trauma-associated liver inflammation and damage.
  • Suppressing NF-κB activation effectively reduces the release of TNF-α and IL-6 post-liver trauma.
  • Targeting NF-κB presents a promising therapeutic avenue for mitigating liver injury following trauma.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...